You are here

Nimbus Therapeutics

After two Big Pharma deals, Nimbus looks to keep the hits coming

Pharma Voice

Mon, 06/3/24 - 12:01 pm

Nimbus Therapeutics

Gilead Sciences

ASCO24: Nimbus Plots Path for Next-Gen IO Therapies with Strong Early HPK1 Blocker Data

BioSpace

Fri, 05/24/24 - 11:31 am

Nimbus Therapeutics

clinical trials

JPM 24: How Takeda beat 'almost every biopharmaceutical company' to win Nimbus’ TYK2 med

Fierce Biotech

Thu, 01/11/24 - 11:17 am

Nimbus Therapeutics

Fresh off $4B deal, Nimbus gears up for ‘third chapter’ with new fundraise

BioPharma Dive

Wed, 09/6/23 - 10:08 am

Nimbus Therapeutics

Nimbus hopes to strike thrice

EP Vantage

Tue, 02/7/23 - 11:08 am

Nimbus Therapeutics

Takeda focuses on ‘diverse’ pipeline prospects on heels of two acquisitions

Endpoints

Mon, 02/6/23 - 10:55 am

Nimbus Therapeutics

colorectal cancer

10 clinical trials to watch in the first half of 2023

BioPharma Dive

Tue, 01/3/23 - 10:57 am

clinical trials

Alzheimer's disease

Huntington's disease

Nimbus Therapeutics

Moderna Therapeutics

Gilead Sciences

Takeda wagers up to $6B on Nimbus’ TYK2 drug

BioPharma Dive

Tue, 12/13/22 - 10:43 am

Nimbus Therapeutics

autoimmune diseases

Nimbus on cloud 9 as psoriasis data support taking rival to Bristol Myers' Sotyktu into phase 3

Fierce Biotech

Wed, 11/30/22 - 10:38 am

Nimbus Therapeutics

Bristol Myers Squibb

clinical trials

Nimbus raises $125M to advance rival to Bristol Myers’ new psoriasis drug

BioPharma Dive

Mon, 09/12/22 - 11:39 pm

Nimbus Therapeutics

Bristol Myers Squibb

Next-gen psoriasis drug rivalry between Bristol Myers and Nimbus spills into a legal battle

Endpoints

Tue, 08/17/21 - 10:56 pm

Bristol Myers Squibb

Nimbus Therapeutics

deucravacitinib

Celgene bags option on Nimbus' anticancer HPK1 inhibitor

Fierce Biotech

Tue, 07/9/19 - 08:45 am

Nimbus Therapeutics

HPK1 inhibitors